BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 24482965)

  • 1. Biologics in SLE: the current status.
    Rajadhyaksha AG; Mehra S; Nadkar MY
    J Assoc Physicians India; 2013 Apr; 61(4):262-7. PubMed ID: 24482965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging biological drugs: a new therapeutic approach for Systemic Lupus Erythematosus. An update upon efficacy and adverse events.
    Murdaca G; Colombo BM; Puppo F
    Autoimmun Rev; 2011 Nov; 11(1):56-60. PubMed ID: 21835271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologicals for the treatment of systemic lupus erythematosus?
    Gunnarsson I; van Vollenhoven RF
    Ann Med; 2012 May; 44(3):225-32. PubMed ID: 21495789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current role of rituximab in systemic lupus erythematosus.
    Mok CC
    Int J Rheum Dis; 2015 Feb; 18(2):154-63. PubMed ID: 25522652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell-targeted therapy for systemic lupus erythematosus.
    Sabahi R; Anolik JH
    Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Belimumab: review of use in systemic lupus erythematosus.
    Boyce EG; Fusco BE
    Clin Ther; 2012 May; 34(5):1006-22. PubMed ID: 22464040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologics in the treatment of systemic lupus erythematosus.
    Lateef A; Petri M
    Curr Opin Rheumatol; 2010 Sep; 22(5):504-9. PubMed ID: 20502332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus.
    Sthoeger Z; Sharabi A; Mozes E
    J Autoimmun; 2014 Nov; 54():60-71. PubMed ID: 24958634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New treatments for SLE: cell-depleting and anti-cytokine therapies.
    Anolik JH; Aringer M
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):859-78. PubMed ID: 16150407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic therapies in systemic lupus erythematosus.
    Bernal CB; Zamora LD; Navarra SV
    Int J Rheum Dis; 2015 Feb; 18(2):146-53. PubMed ID: 25884458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel treatments for systemic lupus erythematosus.
    Gayed M; Gordon C
    Curr Opin Investig Drugs; 2010 Nov; 11(11):1256-64. PubMed ID: 21157645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Treatments in Lupus.
    Kyttaris VC
    Curr Rheumatol Rep; 2017 Mar; 19(3):10. PubMed ID: 28265845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on belimumab for the management of systemic lupus erythematosus.
    Lutalo PM; D'Cruz DP
    Expert Opin Biol Ther; 2014 Nov; 14(11):1701-8. PubMed ID: 25303323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breaking the ice in systemic lupus erythematosus: belimumab, a promising new therapy.
    Mosak J; Furie R
    Lupus; 2013 Apr; 22(4):361-71. PubMed ID: 23553779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Belimumab: a BLyS-specific inhibitor for systemic lupus erythematosus.
    Wiglesworth AK; Ennis KM; Kockler DR
    Ann Pharmacother; 2010 Dec; 44(12):1955-61. PubMed ID: 21081710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biologics in SLE].
    Karonitsch T; Aringer M
    Wien Med Wochenschr; 2015 Jan; 165(1-2):40-5. PubMed ID: 25411010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell-targeted therapy for systemic lupus erythematosus: an update.
    Ding C; Foote S; Jones G
    BioDrugs; 2008; 22(4):239-49. PubMed ID: 18611066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report.
    Aringer M; Burkhardt H; Burmester GR; Fischer-Betz R; Fleck M; Graninger W; Hiepe F; Jacobi AM; Kötter I; Lakomek HJ; Lorenz HM; Manger B; Schett G; Schmidt RE; Schneider M; Schulze-Koops H; Smolen JS; Specker C; Stoll T; Strangfeld A; Tony HP; Villiger PM; Voll R; Witte T; Dörner T
    Lupus; 2012 Apr; 21(4):386-401. PubMed ID: 22072024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Belimumab for the treatment of systemic lupus erythematosus.
    Jordan N; D'Cruz DP
    Expert Rev Clin Immunol; 2015 Feb; 11(2):195-204. PubMed ID: 25543845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recommendations on the use of belimumab in systemic lupus erythematosus. GEAS-SEMI Clinical Practice Guide].
    Ramos-Casals M; Ruiz-Irastorza G; Jiménez-Alonso J; Khamashta MA;
    Rev Clin Esp (Barc); 2013; 213(1):42-58. PubMed ID: 23266125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.